THAR:Com (Par)/Tharimmune Inc - Stock Price Quote and Dividend Data
THAR STOCK PRICE LATEST CLOSE
$1.05
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Com (Par)/Tharimmune Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Com (Par)/Tharimmune Inc Stock Price Information
52-Week Low/High Stock Price$0.95 - $6.45
Percent Held by Institutions4.73%
Revenue$0
Net Income$-16,018,118
Cash Flow$-13,935,638
EPS-2.02%
Market Cap$2,215,511
PE Ratio0
PE Ratio to Industry123%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-83.33%
Total Return Last 3 Years-99.80%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 09, 2025
Com (Par)/Tharimmune Inc Annual Stock Dividends
No Data available for Payment History.
Com (Par)/Tharimmune Inc Dividend Payment History
| No dividends retrieved for THAR |
Com (Par)/Tharimmune Inc Other Dividend Details
Tharimmune, Inc. is a clinical-stage biotechnology company. Co. is engaged in developing a portfolio of therapeutic candidate for inflammatory and immunologic conditions. It has a transmucosal film product, TH104 in Phase I clinical development, two bispecific candidates and a Picobody candidate in pre-clinical development. TH104 is a transmucosal buccal film embedded with the active compound nalmefene onto a thin film which adheres inside of the mouth on the cheek and biodegrades. TH104 is an ideal product candidate for multiple liver-related and other pruritogenic inflammatory conditions.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Feb. 26, 2025THAR STOCK PRICE DECREASE: Com (Par)/Tharimmune Inc on 02-26-2025 decreased stock price > 10% from $1.69 to $1.41
Feb. 25, 2025THAR STOCK PRICE DECREASE: Com (Par)/Tharimmune Inc on 02-25-2025 decreased stock price > 10% from $1.90 to $1.69
Dec. 07, 2024THAR STOCK PRICE INCREASE: Com (Par)/Tharimmune Inc on 12-07-2024 increased stock price > 10% from $2.03 to $2.25
Nov. 08, 2024THAR STOCK PRICE DECREASE: Com (Par)/Tharimmune Inc on 11-08-2024 decreased stock price > 10% from $2.80 to $2.43
Nov. 01, 2024THAR STOCK PRICE DECREASE: Com (Par)/Tharimmune Inc on 11-01-2024 decreased stock price > 10% from $3.43 to $2.85
Oct. 31, 2024THAR STOCK PRICE INCREASE: Com (Par)/Tharimmune Inc on 10-31-2024 increased stock price > 10% from $2.03 to $3.43
Oct. 17, 2024THAR STOCK PRICE INCREASE: Com (Par)/Tharimmune Inc on 10-17-2024 increased stock price > 10% from $1.93 to $2.50
Oct. 08, 2024THAR STOCK PRICE DECREASE: Com (Par)/Tharimmune Inc on 10-08-2024 decreased stock price > 10% from $2.15 to $1.92
Sep. 26, 2024THAR STOCK PRICE DECREASE: Com (Par)/Tharimmune Inc on 09-26-2024 decreased stock price > 10% from $2.72 to $2.39
Aug. 06, 2024THAR STOCK PRICE DECREASE: Com (Par)/Tharimmune Inc on 08-06-2024 decreased stock price > 10% from $3.12 to $2.70
Apr. 10, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-10-2025 decreased stock price > 10% from $0.65 to $0.52
Apr. 10, 2025SXTP STOCK PRICE DECREASE: 60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $2.87 to $2.50
Apr. 10, 2025BMYMP STOCK PRICE DECREASE: $2 Cv. Pfd./Bristol Myers Squibb Co. on 04-10-2025 decreased stock price > 10% from $1,003.20 to $901.50
Apr. 10, 2025PBMWW STOCK PRICE DECREASE: Wt Exp/Psyence Biomedical Ltd on 04-10-2025 decreased stock price > 10% from $0.03 to $0.02
Apr. 10, 2025UPC STOCK PRICE DECREASE: Ord Shs (New)/Universe Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $3.95 to $3.28
Apr. 10, 2025SXTPW STOCK PRICE DECREASE: Wt Exp/60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.04
Apr. 10, 2025RGBP STOCK PRICE DECREASE: Regen BioPharma Inc on 04-10-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 10, 2025DRRX STOCK PRICE DECREASE: Durect Corp on 04-10-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 10, 2025IXHL STOCK PRICE DECREASE: Incannex Healthcare Inc on 04-10-2025 decreased stock price > 10% from $0.84 to $0.68
Apr. 10, 2025CLABF STOCK PRICE DECREASE: Com No Par/Core One Labs Inc on 04-10-2025 decreased stock price > 10% from $0.09 to $0.04
